◇ Physician-supervised protocols◇ Third-party tested · COA on every lot◇ 99%+ verified purity◇ Cold-chain shipping in 48 hours◇ Licensed in 43 states ◇ Physician-supervised protocols◇ Third-party tested · COA on every lot◇ 99%+ verified purity◇ Cold-chain shipping in 48 hours◇ Licensed in 43 states
Home / Formulary / IGF-1 LR3
Back to formulary
IGF-1 LR3 — LORIUM lyophilised vial LORIUM · 1 mg LYOPHILISED VIAL
Third-party tested · COA included with every lot
Growth ● In stockPrescription required

IGF-1 LR3

IGF-1 analogue

IGF-1 LR3 is a highly potent synthetic analogue of human insulin-like growth factor-1, engineered with an Arginine substitution and an extended peptide sequence. By dramatically reducing binding to inhibitory transport proteins and maximizing receptor affinity, this advanced protocol triggers sustained activation of anabolic pathways to drive deep tissue repair and hyperplasia.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It is dispensed only pursuant to a valid prescription following evaluation by a licensed provider.

Researched effects

Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.

Lean Muscle Growth

Increases long-term lean body mass via satellite cell proliferation.

Advanced Tissue Repair

Accelerates deep recovery of muscles, tendons, and ligaments.

Enhanced Protein Synthesis

Maximizes baseline anabolic processes for rapid physical renewal.

Pathway Activation

Strongly stimulates the central PI3K/Akt/mTOR anabolic pathways.

Hyperplasia Support

Drives cellular proliferation in muscles, tendons, and ligaments.

Optimized Fat Metabolism

Improves cellular glucose utilization and supports fat oxidation.

Structural Bone Health

Promotes long-term bone mineral density and skeletal tissue strength.

Specifications

ClassIGF-1 analogue
CAS number946870-92-4
Molar mass9111.45 g/mol
Available sizes1 mg
AdministrationPremium targeted subcutaneous protocol.
CategoryGrowth
View a sample certificate of analysis →

Clinical references

  1. Frost, R. A., & Lang, C. H. (2007). Regulation of IGF-1 and Skeletal Muscle Growth. Growth Horm IGF Res, 17(5).
  2. Barton-Davis, E. R., et al. (1999). IGF-1 LR3 Increases Muscle Mass and Strength. J Clin Invest, 103(2).
  3. Roh, J. D., et al. (2009). IGF-1 Promotes Vascular Repair and Endothelial Function. Mol Ther, 17(9).
  4. Clemmons, D. R. (2007). Role of IGF-1 in Growth and Metabolism. J Clin Endocrinol Metab, 92(4).
Related

More in Growth

View all →